AI Terminal
Novonesis AS
Director's Dealing • Feb 6, 2020
3377_rpt_2020-02-06_ecbc983f-6f24-43ad-b46b-6860d64012e1.pdf
Director's Dealing
Open in ViewerOpens in native device viewer
Trading by management and close relations of management
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.
| Details of the person discharging managerial responsibilities/person closely associated | ||
|---|---|---|
| Name | Anders Lund | +45 3077 8682 |
| Reason for notification | Carl Ahlgren | |
| Position/status | Executive Vice President, Household Care | +45 3077 2783 |
| Initial notification/ | Initial notification | |
| amendment | Ulrik Wu Svare | |
| +45 3077 3187 | ||
| Details of the issuer | ||
| Entity | Novozymes A/S |
Details of the transaction(s)
LEI code 529900T6WNZXD2R3JW38
| Description: | |||
|---|---|---|---|
| Financial instrument | Shares | ||
| Identification code | ISIN DK0060336014 | ||
| Nature of the transaction | Purchase of shares from exercise of stock options | ||
| Place(s) of transaction(s), | |||
| price(s) and volume(s) | Place(s) | Price(s) | Volume(s) |
| See appendix 1 | See appendix 1 | 32,468 shares | |
| Number of shares: 32,468 Aggregated information |
|||
| Average price, DKK: 203.64 | |||
| Transaction value, DKK: 6,611,662.00 | |||
| Date of the transaction | 2020-05-02 |
February 6, 2020 Company announcement No. 9
Contact information [email protected]
Tobias Cornelius Björklund +45 3077 8682 [email protected]
+45 3077 2783 [email protected]
Ulrik Wu Svare +45 3077 3187 [email protected]
About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energyefficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 10 00 71 27 LEI: 529900T6WNZXD2R3JW38
Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd Denmark
Phone: +45 4446 0000
Details of the person discharging managerial responsibilities/person closely associated
| Name | Anders Lund |
|---|---|
| Reason for notification | |
| Position/status | Executive Vice President, Household Care |
| Initial notification/ | Initial notification |
| amendment |
Details of the issuer
| Entity | Novozymes A/S |
|---|---|
| LEI code | 529900T6WNZXD2R3JW38 |
Details of the transaction(s)
| Description: | ||||
|---|---|---|---|---|
| Financial instrument | Shares | |||
| Identification code | ISIN DK0060336014 | |||
| Nature of the transaction | Shares sold | |||
| Place(s) of transaction(s), | ||||
| price(s) and volume(s) | Place(s) | Price(s) | Volume(s) | |
| Outside a trading venue | 366.4 | 32,468 shares | ||
| Aggregated information | Number of shares: 32,468 | |||
| Average price, DKK: 366.4 | ||||
| Transaction value, DKK: 11,896,275.20 | ||||
| Date of the transaction | 2020-05-02 |
Details of the person discharging managerial responsibilities/person closely associated
| Name | Anders Lund | ||
|---|---|---|---|
| Reason for notification | |||
| Position/status | Executive Vice President, Household Care | ||
| Initial notification/ | Initial notification | ||
| amendment | |||
| Details of the issuer | |||
| Entity | Novozymes A/S | ||
| LEI code | 529900T6WNZXD2R3JW38 | ||
| Details of the transaction(s) | |||
| Description: | |||
| Financial instrument | Shares | ||
| Identification code | ISIN DK0060336014 | ||
| Nature of the transaction | Shares sold | ||
| Place(s) of transaction(s), | |||
| price(s) and volume(s) | Place(s) | Price(s) | Volume(s) |
| See appendix 2 | See appendix 2 | 10,000 shares | |
| Aggregated information | Number of shares: 10,000 | ||
| Average price, DKK: 368.01 | |||
| Transaction value, DKK: 3,680,106 | |||
| Date of the transaction | 2020-05-02 |
Appendix 1
| Volume | Price | Venue | Time |
|---|---|---|---|
| 10606 | 178 | Novozymes' custody account | 20200205 11:42:59 |
| 10290 | 197.6 | Novozymes' custody account | 20200205 11:42:59 |
| 11572 | 232.5 | Novozymes' custody account | 20200205 11:42:59 |
Appendix 2
| Venue | Volume | Price | Time |
|---|---|---|---|
| XCSE | S | 13 | 368 | 20200205 13:31:35,505355 +0000 |
|---|---|---|---|---|
| XCSE | S | 100 | 368 | 20200205 13:31:35,505390 +0000 |
| XCSE | S | 40 | 368 | 20200205 13:31:35,505444 +0000 |
| XCSE | S | 150 | 368 | 20200205 13:31:35,505480 +0000 |
| XCSE | S | 160 | 368 | 20200205 13:31:38.915837 +0000 |
| XCSE | S | 340 | 368 | 20200205 13:31:38.915868 +0000 |
| XCSE | S | 163 | 368 | 20200205 13:31:38.964934 +0000 |
| XCSE | S | 197 | 368 | 20200205 13:31:39.013108 +0000 |
| XCSF | S | 140 | 368 | 20200205 13:31:44.975023 +0000 |
| XCSE | S | 300 | 368 | 20200205 13:31:49.061044 +0000 |
| XCSE | S | 200 | 368 | 20200205 13:31:49.061076 +0000 |
| XCSE | S | 200 | 368 | 20200205 13:31:49.061083 +0000 |
| XCSE | S | 200 | 368 | 20200205 13:31:49.061121 +0000 |
| XCSE | S | 200 | 368 | 20200205 13:31:49.082042 +0000 |
| XCSE | S | 300 | 368 | 20200205 13:31:49.082064 +0000 |
| XCSE | S | 233 | 368 | 20200205 13:31:52.510587 +0000 |
| XCSE | S | 267 | 368 | 20200205 13:31:52.510645 +0000 |
| XCSE | S | 172 | 368 | 20200205 13:31:52.562604 +0000 |
| XCSE | S | 328 | 368 | 20200205 13:31:54.796922 +0000 |
| XCSE | S | 52 | 368 | 20200205 13:31:54.922494 +0000 |
| XCSE | S | 286 | 368 | 20200205 13:32:03.335392 +0000 |
